Ardelyx (ARDX) Cash from Operations Growth (5y) (2018 - 2026)
Ardelyx (ARDX) Cash from Operations Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.12% |
| Dec 31, 2025 | 26.12% |
| Sep 30, 2025 | 15.08% |
| Jun 30, 2025 | -5.91% |
| Mar 31, 2025 | -9.04% |
| Dec 31, 2024 | 23.57% |
| Sep 30, 2024 | 15.15% |
| Jun 30, 2024 | 6.96% |
| Mar 31, 2024 | -16.13% |
| Dec 31, 2023 | 13.91% |
| Sep 30, 2023 | 4.50% |
| Jun 30, 2023 | 3.94% |
| Mar 31, 2023 | -45.78% |
| Dec 31, 2022 | 24.91% |
| Sep 30, 2022 | -5.73% |
| Jun 30, 2022 | -5.54% |
| Mar 31, 2022 | -0.63% |
| Dec 31, 2021 | -8.09% |
| Sep 30, 2021 | -7.02% |
| Jun 30, 2021 | -6.60% |